I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
An Investigator-Initiated Phase 2 Study of Nivolumab Plus L..:
Hisato Kawakami
;
Shuichi Hironaka
;
Taito Esaki
...
https://www.mdpi.com/2072-6694/13/4/805. , 2021
Link:
https://doi.org/10.3390/cancers13040805
RT Journal T1
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:11d56b2c1d7c463d84d70b533dcdbe8d&Exemplar=1&LAN=DE A1 Hisato Kawakami A1 Shuichi Hironaka A1 Taito Esaki A1 Kazuaki Chayama A1 Masahiro Tsuda A1 Naotoshi Sugimoto A1 Shigenori Kadowaki A1 Akitaka Makiyama A1 Nozomu Machida A1 Hidekazu Hirano A1 Kenro Hirata A1 Hiroki Hara A1 Hiroshi Yabusaki A1 Yoshito Komatsu A1 Kei Muro PB MDPI AG YR 2021 K1 gastric cancer K1 microsatellite instability K1 nivolumab K1 ipilimumab K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/13/4/805 LK http://dx.doi.org/https://doi.org/10.3390/cancers13040805 DO https://doi.org/10.3390/cancers13040805 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)